Anti-inflammatory drugs may improve survival from severe malaria
A novel anti-inflammatory drug could help to improve survival in the most severe cases of malaria by preventing the immune system from causing irrevocable brain and tissue damage. View More (2012-05-24)
Cardio fitness levels of breast cancer patients may affect survival
Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center. View More (2012-05-24)
VCU Massey Cancer Center sees potential in novel leukemia treatment
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually. View More (2012-05-23)
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial. View More (2012-05-17)
Chemotherapy's effect on overall survival seems to increase based on tumor size
The most recent research released in June's Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with node negative non-small cell lung cancer. View More (2012-05-16)
Living longer - variability in infection-fighting genes can be a boon for male survival
Females of mammals (including humans) tend to outlive males, a circumstance that is usually attributed to males' more aggressive and hence energy-depleting behaviour, especially when they compete for females. View More (2012-05-14)
Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Patients with head and neck cancer and a low haemoglobin (Hb) level do not respond well to radiotherapy and therefore both control of their tumour and disease-free survival are compromised. View More (2012-05-11)
Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
Using a concentrated, highly targeted dose of radiation to the breast has equally good results as irradiating the whole area, with no adverse effects on survival and a much better cosmetic outcome, Hungarian researchers have found. View More (2012-05-11)
HPV-positive throat cancer patients respond better to radiotherapy alone than HPV-negative patients
New findings from a large Danish database of cancer patients suggest that, even though the human papilloma virus (HPV) can trigger throat cancer, patients who are HPV-positive and are light smokers, or don't smoke at all, have a good response to treatment using radiotherapy alone, without the addition of chemotherapy with its consequent toxic side-effects. View More (2012-05-10)
Study says screening accounts for much of black/white disparity in colorectal cancer
A new study finds differences in screening account for more than 40 percent of the disparity in colorectal cancer incidence and nearly 20 percent of colorectal cancer mortality between blacks and whites. View More (2012-05-04)
When to have kids: a complex question for Hazel dormice
Dr. Claudia Bieber from the Research Institute of Wildlife Ecology (FIWI) of the University of Veterinary Medicine, Vienna, and fellow scientists analysed a capture-recapture data set on common dormice (Muscardinus avellanarius) to investigate the life-history strategy of this species. View More (2012-04-30)
Intensive kidney dialysis indicates better survival rates than conventional dialysis
Patients suffering with end-stage renal disease could increase their survival chances by undergoing intensive dialysis at home rather than the conventional dialysis in clinics. View More (2012-04-26)
Study suggests atrial fibrillation should be surgically treated when performing cardiac surgery
A recent study conducted by Northwestern Medicine researchers published in the Journal of Thoracic and Cardiovascular Surgery, reveals that patients with an abnormal heart rhythm known as atrial fibrillation (A-fib) who are undergoing cardiac surgery, have a lower long-term survival rate compared with patients who are in sinus rhythm, which is the normal beating of the heart. View More (2012-04-26)
New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland. View More (2012-04-18)
Researchers have identified a gene with a key role in neuronal survival
Researchers at the Institute of Neurosciences at Universitat Autònoma de Barcelona (INc-UAB) identified the fundamental role played by the Nurr1 gene in neuron survival associated with synaptic activity. View More (2012-04-17)
Heart failure patients with diabetes may benefit from higher glucose levels
Lowering glucose levels for people with diabetes is normally critical to improving health outcomes. But for those with heart failure, that might not always be the case, say UCLA researchers. View More (2012-04-10)
Researchers identify genes that may help in ovarian cancer diagnosis and prognosis
Scientists from Duke University Medical Center have determined that genes acting as molecular "on/off" switches can define clinically relevant molecular subtypes of ovarian cancer, providing ideal potential targets for use in clinical prognostic and diagnostic testing. View More (2012-04-09)
Moffitt Cancer Center Researchers Validate New Staging Classifications for Neuroendocrine Pancreatic Tumor Surgery Response
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. View More (2012-04-04)
Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. View More (2012-04-04)
Feinstein Institute scientists present data about glioblastoma at AACR Annual Meeting
Scientists from the Feinstein Institute for Medical Research will present three abstracts about Glioblastoma multiforme (GBM), the most common and deadly adult brain cancer, at the American Association for Cancer Research (AACR) Annual Meeting to be held from Saturday through Wednesday (March 31- April 4) in Chicago, IL. View More (2012-04-04)
|
|
